Retrieve available abstracts of 2 articles: HTML format
Single Articles
October 2023
FORD AC, Wright-Hughes A, Alderson SL, Ow PL, et al Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as
Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind,
placebo-controlled, phase 3 trial.
Lancet. 2023 Oct 16:S0140-6736(23)01523-4. doi: 10.1016/S0140-6736(23)01523. PubMedAbstract available
DE WIT N, Keszthelyi D Low-dose amitriptyline in irritable bowel syndrome: ready for primary care?
Lancet. 2023 Oct 16:S0140-6736(23)01725-7. doi: 10.1016/S0140-6736(23)01725. PubMed